Position in DRTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,870
+$2,609 QoQ
Shares Held
1,500
-34.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 74 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DRTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Altshuler Shaham Ltd holds $5,906,247 across 17 Biotechnology names. DRTS ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UPB |
Upstream Bio, Inc.
|
380,061 | $2,630,022 | |
| 2 | CGEN |
Compugen Ltd
|
521,625 | $1,116,277 | |
| 3 | MRNA |
Moderna, Inc.
|
15,100 | $1,057,453 | |
| 4 | VYGR |
Voyager Therapeutics, Inc.
|
142,200 | $497,700 | |
| 5 | HELP |
Cybin Inc.
|
72,000 | $475,920 | |
| 6 | ORMP |
Oramed Pharmaceuticals Inc.
|
11,211 | $53,924 | |
| 7 | DRTS |
Alpha Tau Medical Ltd.
This page
|
1,500 | $18,870 | |
| 8 | PLX |
Protalix BioTherapeutics, Inc.
|
7,742 | $18,038 |
All Filings in DRTS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,870 | 1,500 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $16,261 | 2,300 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $17,820 | 3,600 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,118 | 1,800 | Shares | Defined | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||